JP2003523772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003523772A5 JP2003523772A5 JP2001562706A JP2001562706A JP2003523772A5 JP 2003523772 A5 JP2003523772 A5 JP 2003523772A5 JP 2001562706 A JP2001562706 A JP 2001562706A JP 2001562706 A JP2001562706 A JP 2001562706A JP 2003523772 A5 JP2003523772 A5 JP 2003523772A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding domain
- igg
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51113900A | 2000-02-23 | 2000-02-23 | |
| US09/511,139 | 2000-02-23 | ||
| US09/791,153 US20030103978A1 (en) | 2000-02-23 | 2001-02-22 | Selective binding agents of osteoprotegerin binding protein |
| US09/791,153 | 2001-02-22 | ||
| PCT/US2001/005973 WO2001062932A1 (en) | 2000-02-23 | 2001-02-23 | Antagonistic selective binding agents of osteoprotegerin binding protein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008237535A Division JP5279425B2 (ja) | 2000-02-23 | 2008-09-17 | オステオプロテゲリン結合タンパク質のアンタゴニスト性選択的結合因子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003523772A JP2003523772A (ja) | 2003-08-12 |
| JP2003523772A5 true JP2003523772A5 (https=) | 2008-03-13 |
| JP4401613B2 JP4401613B2 (ja) | 2010-01-20 |
Family
ID=27057130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001562706A Expired - Lifetime JP4401613B2 (ja) | 2000-02-23 | 2001-02-23 | オステオプロテゲリン結合タンパク質のアンタゴニスト性選択的結合因子 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1257648B2 (https=) |
| JP (1) | JP4401613B2 (https=) |
| AU (1) | AU3868001A (https=) |
| CA (1) | CA2400929C (https=) |
| DE (1) | DE60134459D1 (https=) |
| DK (1) | DK2105449T3 (https=) |
| MX (1) | MXPA02008144A (https=) |
| SI (1) | SI1257648T2 (https=) |
| WO (1) | WO2001062932A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69740107D1 (de) | 1996-12-23 | 2011-03-10 | Immunex Corp | Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie |
| ES2284203T5 (es) | 1997-04-16 | 2016-03-11 | Amgen Inc. | Proteínas de unión a osteoprotegerina y sus receptores |
| US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
| AU762574B2 (en) | 1998-05-14 | 2003-06-26 | Immunex Corporation | Method of inhibiting osteoclast activity |
| WO2002024896A2 (en) | 2000-09-22 | 2002-03-28 | Immunex Corporation | Screening assays for agonists or antagonists of receptor activat or of nf-kb |
| EP2295081B1 (en) | 2001-06-26 | 2018-10-31 | Amgen Inc. | Antibodies to OPGL |
| DE10210427A1 (de) * | 2002-03-09 | 2003-10-09 | Hans Konrad Mueller-Hermelink | Humaner monoklonaler Antikörper |
| US7718776B2 (en) | 2002-04-05 | 2010-05-18 | Amgen Inc. | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| EP1521776A2 (en) | 2002-07-04 | 2005-04-13 | Oncomab Gmbh | Neoplasm specific antibodies and uses thereof |
| DE10311248A1 (de) | 2003-03-14 | 2004-09-30 | Müller-Hermelink, Hans Konrad, Prof. Dr. | Humaner monoklonaler Antikörper |
| CA2523912A1 (en) | 2003-04-30 | 2004-11-11 | Japan Science And Technology Agency | Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| WO2005030793A2 (en) | 2003-09-24 | 2005-04-07 | Millennium Pharmaceuticals, Inc. | Antibodies which bind human cxcr3 |
| DE10353175A1 (de) | 2003-11-14 | 2005-06-16 | Müller-Hermelink, Hans Konrad, Prof. Dr. | Humaner monoklonaler Antikörper mit fettsenkender Wirkung |
| EP1531162A1 (en) | 2003-11-14 | 2005-05-18 | Heinz Vollmers | Adenocarcinoma specific antibody SAM-6, and uses thereof |
| US20060099203A1 (en) | 2004-11-05 | 2006-05-11 | Pease Larry R | B7-DC binding antibody |
| WO2006004988A2 (en) * | 2004-06-30 | 2006-01-12 | Mayo Foundation For Medical Education And Research | B7-dc binding antibody |
| US7501119B2 (en) | 2004-06-30 | 2009-03-10 | Mayo Foundation For Medical Education And Research | Methods and molecules for modulating an immune response |
| EP3030249B1 (en) | 2013-08-07 | 2019-12-25 | Rigshospitalet, Copenhagen University Hospital | Antibodies, compounds and derivatives thereof for use in the treatment of male infertility |
| HUE056378T2 (hu) | 2013-09-13 | 2022-02-28 | Univ Chiba Nat Univ Corp | R-Ketamin és sójának alkalmazása gyógyszerekként |
| US11980595B2 (en) | 2018-02-15 | 2024-05-14 | National University Corporation Chiba University | Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases |
| WO2019213551A1 (en) | 2018-05-04 | 2019-11-07 | Perception Neuroscience, Inc. | Methods of treating substance abuse |
| AU2023329315A1 (en) | 2022-08-24 | 2025-01-16 | Amgen Inc. | Anti-drug antibody assays |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1114864E (pt) † | 1996-12-13 | 2008-10-08 | Schering Corp | Antigénios de superfície de células de mamífero, reagentes relacionados |
| DE69740107D1 (de) † | 1996-12-23 | 2011-03-10 | Immunex Corp | Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie |
| ES2263204T5 (es) † | 1997-04-15 | 2013-10-14 | Daiichi Sankyo Company, Limited | Nueva proteína y proceso para producir la misma |
| ES2284203T5 (es) † | 1997-04-16 | 2016-03-11 | Amgen Inc. | Proteínas de unión a osteoprotegerina y sus receptores |
| HUP0103578A3 (en) † | 1998-09-15 | 2005-11-28 | Pharmexa As | Method for down-regulating osteoprotegerin ligand activity |
-
2001
- 2001-02-23 SI SI200130847A patent/SI1257648T2/sl unknown
- 2001-02-23 DK DK08010991.1T patent/DK2105449T3/da active
- 2001-02-23 AU AU3868001A patent/AU3868001A/xx active Pending
- 2001-02-23 WO PCT/US2001/005973 patent/WO2001062932A1/en not_active Ceased
- 2001-02-23 JP JP2001562706A patent/JP4401613B2/ja not_active Expired - Lifetime
- 2001-02-23 CA CA2400929A patent/CA2400929C/en not_active Expired - Lifetime
- 2001-02-23 DE DE60134459T patent/DE60134459D1/de not_active Expired - Lifetime
- 2001-02-23 EP EP01911158.2A patent/EP1257648B2/en not_active Expired - Lifetime
- 2001-02-23 MX MXPA02008144A patent/MXPA02008144A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003523772A5 (https=) | ||
| CN106519034B (zh) | 抗pd-1抗体及其用途 | |
| KR102068600B1 (ko) | Pdl-1 항체, 그 약학적 조성물 및 그 용도 | |
| CN113767113B (zh) | 密封蛋白6抗体及其用途 | |
| KR101307868B1 (ko) | Ｍ-ｃｓｆ-특이적 단일클론 항체 및 그것의 사용 | |
| RU2349340C2 (ru) | Биспецифические антитела к erb-b и их применение для лечения опухолей | |
| CN110799540B (zh) | 多特异性抗体及其制备和使用方法 | |
| CA2400929A1 (en) | Antagonistic selective binding agents of osteoprotegerin binding protein | |
| EP3645741A2 (en) | Anti-4-1bb antibodies and methods of making and using thereof | |
| RU2018142544A (ru) | Биспецифические связывающие белки и пути их применения | |
| CN107001471B (zh) | 抗met抗体和组合物 | |
| CN112566936B (zh) | 针对人tim-3的单克隆抗体 | |
| JP2005508176A5 (https=) | ||
| JP2018533371A5 (https=) | ||
| JP2004531217A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2019520797A5 (https=) | ||
| HRP20110187T1 (hr) | Multispecifične deimunizirane tvari koje vežu cd3 | |
| JP2012518039A5 (https=) | ||
| MX2010009894A (es) | Anticuerpo contra csf-1r. | |
| WO2005056600B1 (en) | Monoclonal antibodies that bind or neutralize dengue virus | |
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| JP2022533538A5 (https=) | ||
| RU2012137490A (ru) | Антитела с рн-зависимым связыванием антигена | |
| EP1082141A4 (en) | CD40 AND CTL PEPTIDES BINDING MOLECULES FOR THE TREATMENT OF TUMORS |